Sergio Traversa Relmada Therapeutics, Inc. (RLMD) insider trading activity

Sergio Traversa is Chief Executive Officer of RELMADA THERAPEUTICS, INC.. Currently has a direct ownership of 384,024 shares of RLMD, which is worth approximately $1.26 Million. The most recent transaction as insider was on Sep 11, 2024, when has been sold 51,407 shares (Common Stock) at a price of $2.99 per share, resulting in proceeds of $153,706. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 384K

57.37% 3M change

166.64% 12M change

Total Value Held $1.26 Million

SERGIO TRAVERSA Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 11 2024	BUY Open market or private purchase	$153,706 $2.99 p/Share	51,407 Added 11.81%	384,024 Common Stock
Sep 10 2024	BUY Open market or private purchase	$90,788 $2.75 p/Share	33,014 Added 9.03%	332,617 Common Stock
Sep 09 2024	BUY Open market or private purchase	$150,619 $2.71 p/Share	55,579 Added 15.65%	299,603 Common Stock
Jan 31 2024	BUY Open market or private purchase	$109,840 $4.0 p/Share	27,460 Added 10.11%	244,024 Common Stock
Jan 30 2024	BUY Open market or private purchase	$159,896 $3.9 p/Share	40,999 Added 15.92%	216,564 Common Stock
Jan 29 2024	BUY Open market or private purchase	$117,017 $3.71 p/Share	31,541 Added 15.23%	175,565 Common Stock
Dec 08 2022	BUY Open market or private purchase	$116,025 $2.1 p/Share	55,250 Added 27.73%	144,024 Common Stock
Jul 01 2022	SELL Open market or private sale	$253,367 $18.42 p/Share	13,755 Reduced 13.42%	88,774 Common Stock
Jul 01 2022	BUY Exercise of conversion of derivative security	$220,080 $16.0 p/Share	13,755 Added 11.83%	102,529 Common Stock
Jun 30 2022	SELL Open market or private sale	$307,270 $19.19 p/Share	16,012 Reduced 15.28%	88,774 Common Stock
Jun 30 2022	BUY Exercise of conversion of derivative security	$256,192 $16.0 p/Share	16,012 Added 13.26%	104,786 Common Stock
Mar 10 2021	SELL Open market or private sale	$104,673 $35.09 p/Share	2,983 Reduced 3.25%	88,774 Common Stock
Mar 09 2021	SELL Open market or private sale	$251,700 $35.87 p/Share	7,017 Reduced 7.1%	91,757 Common Stock
Mar 09 2021	BUY Exercise of conversion of derivative security	$32,400 $3.24 p/Share	10,000 Added 9.19%	98,774 Common Stock
Feb 24 2021	SELL Open market or private sale	$346,500 $34.65 p/Share	10,000 Reduced 10.12%	88,774 Common Stock
Feb 24 2021	BUY Exercise of conversion of derivative security	$32,400 $3.24 p/Share	10,000 Added 9.19%	98,774 Common Stock
Feb 11 2021	SELL Open market or private sale	$51,232 $35.43 p/Share	1,446 Reduced 1.6%	88,774 Common Stock
Feb 11 2021	BUY Exercise of conversion of derivative security	$4,685 $3.24 p/Share	1,446 Added 1.58%	90,220 Common Stock
Feb 10 2021	SELL Open market or private sale	$68,090 $35.28 p/Share	1,930 Reduced 2.13%	88,774 Common Stock
Feb 09 2021	SELL Open market or private sale	$209,957 $35.21 p/Share	5,963 Reduced 6.17%	90,704 Common Stock
Feb 08 2021	SELL Open market or private sale	$116,054 $35.03 p/Share	3,313 Reduced 3.31%	96,667 Common Stock
Feb 08 2021	BUY Exercise of conversion of derivative security	$36,307 $3.24 p/Share	11,206 Added 10.08%	99,980 Common Stock
Feb 03 2021	SELL Open market or private sale	$3,500 $35.0 p/Share	100 Reduced 0.11%	88,874 Common Stock
Feb 02 2021	SELL Open market or private sale	$111,484 $35.08 p/Share	3,178 Reduced 3.45%	88,874 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$10,621 $3.24 p/Share	3,278 Added 3.44%	92,052 Common Stock

Sergio Traversa

Chief Executive Officer

Coral Gables,, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLMD shares.

Notify only if

Value

Insider Trading

Get notified when an Relmada Therapeutics, Inc. insider buys or sells RLMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to RELMADA THERAPEUTICS, INC.

Track Activities on RLMD

Account